DANSK BYPLANLABORATORIUM. FOND TIL BYPLANLÆGNINGENS FREMME

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.2% 5.0% 8.2% 1.4% 1.5%  
Credit score (0-100)  9 42 29 77 76  
Credit rating  BB BBB BB A A  
Credit limit (kDKK)  0.0 0.0 0.0 55.0 23.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  3,264 7,823 8,958 9,871 11,383  
Gross profit  3,264 7,823 8,958 7,675 7,144  
EBITDA  -1,586 1,945 -300 929 526  
EBIT  -1,586 1,945 -300 908 508  
Pre-tax profit (PTP)  -1,600.0 1,933.0 -330.0 930.1 530.0  
Net earnings  -1,600.0 1,933.0 -330.0 713.7 417.0  
Pre-tax profit without non-rec. items  -1,586 1,945 -300 930 530  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 56.4 38.1  
Shareholders equity total  1,312 3,244 2,915 3,628 4,045  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,822 6,651 5,701 6,943 7,506  

Net Debt  0.0 0.0 0.0 -3,678 -2,372  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  3,264 7,823 8,958 9,871 11,383  
Net sales growth  -59.1% 139.7% 14.5% 10.2% 15.3%  
Gross profit  3,264 7,823 8,958 7,675 7,144  
Gross profit growth  -59.1% 139.7% 14.5% -14.3% -6.9%  
Employees  0 0 0 10 9  
Employee growth %  0.0% 0.0% 0.0% 0.0% -10.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,822 6,651 5,701 6,943 7,506  
Balance sheet change%  -23.9% 37.9% -14.3% 21.8% 8.1%  
Added value  -1,586.0 1,945.0 -300.0 908.2 525.9  
Added value %  -48.6% 24.9% -3.3% 9.2% 4.6%  
Investments  0 0 0 36 -37  

Net sales trend  -1.0 1.0 2.0 3.0 4.0  
EBIT trend  -1.0 1.0 -1.0 1.0 2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  -48.6% 24.9% -3.3% 9.4% 4.6%  
EBIT %  -48.6% 24.9% -3.3% 9.2% 4.5%  
EBIT to gross profit (%)  -48.6% 24.9% -3.3% 11.8% 7.1%  
Net Earnings %  -49.0% 24.7% -3.7% 7.2% 3.7%  
Profit before depreciation and extraordinary items %  -49.0% 24.7% -3.7% 7.4% 3.8%  
Pre tax profit less extraordinaries %  -48.6% 24.9% -3.3% 9.4% 4.7%  
ROA %  -28.4% 33.9% -4.9% 14.7% 7.3%  
ROI %  -28.4% 33.9% -4.9% 19.9% 13.8%  
ROE %  -75.8% 84.9% -10.7% 21.8% 10.9%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  100.0% 100.0% 100.0% 74.6% 74.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 33.5% 30.3%  
Relative net indebtedness %  0.0% 0.0% 0.0% -3.7% 9.5%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -396.0% -451.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 0.0 0.0 5.4 5.2  
Current Ratio  0.0 0.0 0.0 2.0 2.1  
Cash and cash equivalent  0.0 0.0 0.0 3,677.5 2,371.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 67.4 83.8  
Trade creditors turnover (days)  0.0 0.0 0.0 8.5 4.2  
Current assets / Net sales %  0.0% 0.0% 0.0% 67.3% 63.5%  
Net working capital  0.0 0.0 0.0 3,337.8 3,775.3  
Net working capital %  0.0% 0.0% 0.0% 33.8% 33.2%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 987 1,265  
Added value / employee  0 0 0 91 58  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 93 58  
EBIT / employee  0 0 0 91 56  
Net earnings / employee  0 0 0 71 46